Anyone who took Invokana and suffered heart attack, stroke, kidney failure or ketoacidosis.
What's Going On?
Attorneys across the country are speaking with Invokana users and their loved ones to determine whether lawsuits can be filed against the drug's maker, Janssen Pharmaceuticals. The attorneys have reason to believe Invokana is causing serious health problems due to a defect in its design. They also suspect the maker of Invokana didn't properly warn patients about the drug's risks.
How Can a Lawsuit Help?
A lawsuit can help provide compensation for medical bills, lost earnings and, in the event of death, funeral expenses. It can also help hold Janssen Pharmaceuticals accountable for selling an allegedly defective drug.
Type of Lawsuit
Reports have surfaced that the type 2 diabetes drug can lead to ketoacidosis, a serious condition that causes the body to produce too much acid in the blood. One study required by the FDA also found that Invokana users had a 690% greater risk of suffering cardiovascular damage.
If you or a loved one suffered any of the following side effects after taking Invokana, you may be able to sue the manufacturer for medical bills and other expenses:
Diabetic ketoacidosis (DKA)
What’s Causing These Side Effects?
Attorneys believe there is a problem with Invokana’s design. Allegedly, Invokana puts too much pressure on the kidneys – pressure that the body can’t handle. This, in turn, may lead to kidney failure, cardiovascular failure, diabetic ketoacidosis and stroke. The attorneys believe that Janssen Pharmaceuticals didn’t do enough to warn patients and doctors about these risks.
FDA Warns Invokana Can Cause Ketoacidosis
In May 2015, the FDA released a warning that said certain Type 2 diabetes medications belonging to a class of drugs known as SGLT2 inhibitors could cause ketoacidosis.
These drugs include:
Invokamet (canagliflozin and metformin)
Xigduo XR (dapagliflozin and metformin extended-release)
Glyxambi (empagliflozin and linagliptin)
Ketoacidosis develops when too much acid builds up in the blood and can result in extended hospitalization, diabetic coma or even death.
FDA Receives Dozens of Reports of Ketoacidosis
In its warning, the FDA said that between March 2013 and June 2014 it received at least 20 reports of diabetic ketoacidosis (DKA), ketoacidosis or ketosis in patients taking SGLT2 inhibitors. The agency reported that all of these patients required hospitalization or emergency room visits. Since then, the agency has continued to receive reports of DKA and ketoacidosis in patients taking these medications.
How Can a Lawsuit Help Me?
A lawsuit can help Invokana patients and their loved ones recover compensation for:
Pain and suffering
Funeral expenses in the event of death
A lawsuit can also help hold Janssen Pharmaceuticals accountable for releasing a potentially dangerous drug into the marketplace.